Thyroid testing in acutely ill patients may be an expensive distraction
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
In health, an efficient negative feedback mechanism maintains serum thyroid hormone concentrations within an exquisitely controlled narrow range.Therefore any change that occurs to thyroid hormones in intrinsic thyroid disease is concordant and easy to interpret.Optimal functioning of the many tissues they influence is thereby facilitated.The situation in acute illnesses is different.Mechanisms that operate in these circumstances influence the hypothalamic-pituitary-thyroid axis and its components producing thyroid test results, which are discordant, do not fit recognizable patterns and are difficult to interpret.The yield of abnormalities is also low (about 7%).As many studies indicate, thyroid tests are expensive and consume large amounts of the hospital budget and resources of hospital laboratories.Other studies have shown that when abnormalities are detected, clinicians do not intervene or follow up these subjects.Therefore the clinical utility of thyroid testing in acutely ill patients is debatable.Interventions to change requestor behaviour with regard to thyroid testing in acutely ill subjects and the success of some audit and educational interventions are worthy of note.Thyroid testing in acutely ill patients is often an expensive distraction and is of limited clinical value.Targeted thyroid testing should be offered in this group only to those with: (a) symptoms or signs of thyroid disease e.g.goiter or orbitopathy; (b) risk factors for thyroid disease, previous or family history of thyroid disease; (c) taking drugs which potentially affect thyroid function e.g.thyroxine replacement therapy, amiodarone, lithium, mechanistic target of rapamycin (mTOR) inhibitors, interferon, alemtuzumab etc; (d) unexplained tachydysrhythmias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deiodinases: implications of the local control of thyroid hormone action
Bianco, A. C., & Kim, B. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29812 · Cited by 845 · cited 1×
“The thyroid secretes its major product the prohormone fT4, stimulated by TSH, which is then converted to the active hormone fT3, by intracellular deiodinase enzymes both in peripheral and central tissues (pituitary and hypothalamus) (19).”
BackgroundAndersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Thyroid function in critically ill patients
Fliers, E., Bianco, A. C., Langouche, L., & Boelen, A. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00225-9 · Cited by 441
Minireview: Thyroid Hormone Transporters: The Knowns and the Unknowns
Visser, W. E., Friesema, E. C. H., & Visser, T. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0095 · Cited by 390
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Van den Berghe, G. (2014) · Thyroid® · doi:10.1089/thy.2014.0201 · Cited by 316
Taylor, P. N., Iqbal, A., Minassian, C., Sayers, A., Draman, M. S., Greenwood, R., Hamilton, W., Okosieme, O., Panicker, V., Thomas, S. L., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11312 · Cited by 300
Pitfalls in the measurement and interpretation of thyroid function tests
Koulouri, O., Moran, C., Halsall, D., Chatterjee, K., & Gurnell, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.003 · Cited by 282
Drugs that suppress TSH or cause central hypothyroidism
Haugen, B. R. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.08.003 · Cited by 252 · cited 1×
“In many instances it is a combination of the two, compounded by the effects of drugs (23,24).”
BackgroundThe molecular basis of the non-thyroidal illness syndrome
de Vries, E. M., Fliers, E., & Boelen, A. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0133 · Cited by 192
Leese, G. P., Flynn, R. V., Jung, R. T., MacDonald, T. M., Murphy, M. J., & Morris, A. D. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03051.x · Cited by 165 · cited 1×
“Clinicians have contributed to an increasing laboratory workload by adopting a very low threshold for testing, in an attempt at diagnosing subtle thyroid dysfunction (10-12).”
BackgroundMECHANISMS IN ENDOCRINOLOGY: Beyond the fixed setpoint of the hypothalamus–pituitary–thyroid axis
Fliers, E., Kalsbeek, A., & Boelen, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0285 · Cited by 124
NEW INSIGHTS INTO THE HYPOTHALAMIC-PITUITARY-THYROID AXIS
Duntas, L. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.125 · Cited by 7
Cited by
Feldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111173 · Cited by 170
“In some clinical situations e.g. critical illness, it is therefore advisable to postpone thyroid function testing until after resolution of the critical non-thyroidal illness, in order to avoid confusing a correct management of such patients (Premawardhana, 2017).”
BackgroundInteractions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions
Feldt-Rasmussen, U., Klose, M., & Benvenga, S. (2018) · Endocrine · doi:10.1007/s12020-018-1738-6 · Cited by 12
Low Yield of Thyroid-Function Tests in Adult Hospitalized Patients — A Retrospective Analysis
Dogra, P., Paudel, R., Panthi, S., Cassity, E., & Tannock, L. R. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s256868 · Cited by 6
Intravenous levothyroxine stewardship program at a tertiary academic medical center
Marino, K. K., Crowley, K. E., Tran, L. K., Sylvia, D., Dell’Orfano, H., DeGrado, J. R., & Szumita, P. M. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab155 · Cited by 1
Metadata
- Authors
- Premawardhana, L. D.
- Venue
- Biochemia Medica
- Published
- 2017-06-15
- Volume
- 27
- Issue
- 300
- Pages
- 300-307
- ISSN
- 1330-0962 (ISSN-L)
- 1846-7482
- OpenAlex
- W2626744367
- Cited by
- 17
- References
- 12
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.